Stockreport

Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products [Yaho...

Celularity Inc. - Class A  (CELU) 
PDF Implements plan to reduce 2024 selling, general & administrative expenses (SG&A), executive cash compensation, reinforces management's alignment of incentives with shar [Read more]